AI & ChatGPT searches , social queriess for GPR55
Search references for GPR55. Phrases containing GPR55
See searches and references containing GPR55!
Search references for GPR55. Phrases containing GPR55
See searches and references containing GPR55!GPR55
Protein-coding gene in the species Homo sapiens
protein-coupled receptor 55 also known as GPR55 is a G protein-coupled receptor that in humans is encoded by the GPR55 gene. GPR55, along with GPR119 and GPR18, have
GPR55
Group of receptors to cannabinoid compounds
Other molecular biology studies have suggested that the orphan receptor GPR55 should in fact be characterised as a cannabinoid receptor, on the basis
Cannabinoid_receptor
Chemical compound
signaling pathways, potentially involving GPR55, a receptor implicated in neuroinflammatory modulation. GPR55 NLRP3 NCX1 Mitochondrial disease G protein-coupled
KLS-13019
Chemical compound
Wagner JA, Kunos G (September 2009). "Receptors for acylethanolamides-GPR55 and GPR119". Prostaglandins & Other Lipid Mediators. 89 (3–4): 105–11. doi:10
Palmitoylethanolamide
Cis enantiomer of tetrahydrocannabidiol
psychoactive, while the others retain activity at targets such as GPR18 and GPR55. Abeo-HHC acetate Abn-CBD CBD-DMH Exo-THC Iso-THC HU-211 Perrottetinene
Cis-THC
Protein-coding gene in humans
receptor that in humans is encoded by the GPR119 gene. GPR119, along with GPR55 and GPR18, have been implicated as novel cannabinoid receptors. GPR119 is
GPR119
Minor cannabinoid
receptors. There is no information on the binding or activity of CBG at the GPR55 (the potential non-homologous CB3 receptor). CBG has relatively low affinity
Cannabigerol
Homologue of tetrahydrocannabinol
lessens the psychoactive effects of THC. THCV also acts as an agonist of GPR55 and l-α-lysophosphatidylinositol (LPI), and beyond the endocannabinoid system
Tetrahydrocannabivarin
Chemical compound
lysophosphatidylinositol (2-ALPI), have been proposed as the endogenous ligands of GPR55. Recent studies have shown that the fatty acyl composition of LPI influences
Lysophosphatidylinositol
Biological system of neurotransmitters
receptors are known to bind endocannabinoids as well, including GPR18, GPR55 (a regulator of neuroimmune function), and GPR119. CB1 has also been noted
Endocannabinoid_system
Synthetic, cannabinoid-like compound
orphan receptor GPR18. Another possible target of abnormal cannabidiol is GPR55, which has also received much attention as a putative cannabinoid receptor
Abnormal_cannabidiol
Chemical compound
Ki values of 0.58 nM and 0.68 nM respectively, but is an antagonist at GPR55, the putative "CB3" receptor. CP 55,940 binding has been detected in the
CP_55,940
THC precursor
the extract that contains THCA, and is mediated, at least partially, via GPR55 receptor. The cytotoxic activity of the C. sativa extract was increased
Tetrahydrocannabinolic_acid
Protein-coding gene in the species Homo sapiens
encoded by the GPR18 gene. Along with the other previously orphan receptors GPR55 and GPR119, GPR18 has been found to be a receptor for endogenous lipid neurotransmitters
NAGly_receptor
Genus of flowering plants
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Cannabis
Chemical compound
a CB2 Ki of 49nM. It is also a weak antagonist at the related receptor GPR55, with an IC50 of 6350nM, but has no significant affinity for GPR18. PSB-SB-487
PSB-SB-1202
Chemical compound
Metabolites: Activation of Cannabinoid CB 2 Receptors and Blockade of the Related GPR55". ACS Medicinal Chemistry Letters. 4 (1): 41–45. doi:10.1021/ml300235q.
Magnolol
Medication for pain and fever
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Paracetamol
Psychoactive drug from the cannabis plant
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Cannabis_(drug)
Phytocannabinoid discovered in 1940
modulator of the CB1 cannabinoid receptor Cannabidiol may be an antagonist of GPR55, a G protein-coupled receptor and putative non-homologous CB3 cannabinoid
Cannabidiol
Plant species
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Cannabis_sativa
Psychoactive component of cannabis
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Tetrahydrocannabinol
Protein-coding gene in the species Homo sapiens
with the secretin receptor (with low affinity), as well as MRGPRX2 and GPR55. Adenylate cyclase Pituitary gland GRCh38: Ensembl release 89: ENSG00000141433
Pituitary adenylate cyclase-activating peptide
Pituitary_adenylate_cyclase-activating_peptide
Designer drugs
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Synthetic_cannabinoids
Chemical compound
GPR55. Unlike older GPR55 antagonists such as O-1918, PSB-SB-487 has good selectivity over the related receptor GPR18, with an IC50 of 113nM at GPR55
PSB-SB-487
Specific cannabis extract
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Nabiximols
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
List_of_cannabinoids
Chemical compound
orphan receptor GPR55, and may be the first selective inverse agonist characterised for this receptor. It was found to block a number of GPR55 mediated responses
CID16020046
Protein-coding gene in the species Homo sapiens
three novel human G protein-coupled receptor genes GPR52, PsiGPR53 and GPR55: GPR55 is extensively expressed in human brain". Brain Research. Molecular Brain
GPR52
Chemical compound
cannabidiol, which is an antagonist at two former orphan receptors GPR18 and GPR55, that appear to be related to the cannabinoid receptors. O-1918 is used
O-1918
Chemical compound
(over 36x selectivity vs CB1 and GPR55, and 14x vs CB2.) As all previously known antagonists for GPR18 also antagonise GPR55, it has been difficult to separate
PSB-CB5
Natural bicyclic sesquiterpene
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Caryophyllene
Chemical compound
appear to be related to the cannabinoid receptors, particularly GPR18 and GPR55. These previously orphan receptors have been found to be targets for a number
O-1602
Chemical compound (fatty acid neurotransmitter)
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Anandamide
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Pregnenolone
Species of plant
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Cannabis_ruderalis
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Oleamide
Interactions in the immune system
process include: Chemokine receptors: CXCR4 Cannabinoid receptors: CB1, CB2, GPR55 Trace amine-associated receptors: TAAR1 μ-Opioid receptors – all subtypes
Neuroimmune_system
Species of plant
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Kava
Mammalian protein found in Homo sapiens
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Fatty-acid_amide_hydrolase_1
Endocannabinoid reuptake inhibitor under development for psychiatric disorders
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
SYT-510
Species of plant
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Cannabis_indica
Pharmaceutical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Z8526711350
Cannabis sativa L. (marijuana; hemp) used medicinally
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Medical_cannabis
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
JWH-018
Synthetic cannabinoid, designer drug
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
ADB-5'Br-PINACA
Pharmaceutical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
ONO-1110
Medication and supplement
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Pregnenolone_(medication)
Chemical compound
HEK-293 cells. The same migration wasn't witnessed using non-transfected and GPR55 transfected HEK-293. Additionally, tetrahydrocannabinol and NaGly are full
N-Arachidonylglycine
Mammalian protein found in humans
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Cannabinoid_receptor_1
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Dimethylheptylpyran
Synthetic cannabinoid
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Nabilone
Phytocannabinoid
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Cannabidiorcol
Naturally-occurring cannabinoid
5-HT1A, A2 and A1 adenosine receptors Highest potency at TRPV1 Antagonist at GPR55, GPR18, 5-HT3A, with highest potency as antagonist at TRPM8 Inverse agonist
Cannabinol
Active metabolite of Δ9-THC
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
11-Hydroxy-THC
Class of endogenous fatty acid compounds
cannabinoid-receptor dependent behaviors including antinociception and anxiolysis. GPR18, GPR55, GPR92 have also been proposed to be activated by various N-acyl amides
N-Acylamides
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Monlunabant
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
MDMB-4en-PINACA
Mammalian protein found in Homo sapiens
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Cannabinoid_receptor_2
Compounds found in cannabis
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Cannabinoid
Pharmaceutical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
AB-5'F-BUTINACA
Drug designed to treat obesity
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Orlistat
Pharmaceutical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Elcubragistat
Pharmaceutical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
ZYN-001
Family of proteins
(GPR17, GPRH) GPR18 (GPR18, GPRI) GPR20 (GPR20, GPRK) GPR35 (GPR35) GPR55 (GPR55) Coagulation factor II receptor (F2R, THRR) Opsins InterPro: IPR001760
Rhodopsin-like_receptors
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Kaempferol
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
CUMYL-4CN-BINACA
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Zevaquenabant
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Gallocatechol
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
JD5037
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Olorinab
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Endocannabinoid_transporter
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Pravadoline
Protein found in ginseng
Hwang SH; Nah SY (2020). "Ginseng Gintonin Contains Ligands for GPR40 and GPR55". Molecules. 25 (5): 1102. doi:10.3390/molecules25051102. PMC 7179172. PMID 32121640
Gintonin
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
A-PONASA
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Honokiol
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Genistein
Pharmaceutical compound
be inactive at both cannabinoid receptors and related receptors such as GPR55, and eventually it was found to be a selective BKCa channel opener. It has
VSN16R
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
ADB-5'F-BUTINACA
Proposed mechanism of cannabis compounds
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Entourage_effect
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
IDFP
Protein-coding gene in the species Homo sapiens
peptide agonist, full length version) - also activates other receptors VIP, GPR55 and MRGPRX2 and the Secretin receptor. PACAP-27 (endogenous peptide agonist
ADCYAP1R1
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Cannabicyclohexanol
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Rimonabant
Class of chemical compounds
Lauckner JE, Jensen JB, Chen HY, Lu HC, Hille B, Mackie K (February 2008). "GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits
N-Acylethanolamine
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Lixosicone
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
CUMYL-3TMS-PRINACA
Main secondary metabolite of THC
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
11-Nor-9-carboxy-THC
Pharmaceutical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Tetrahydrocannabinol/cannabinol/cannabidiol
Tetrahydrocannabinol/cannabinol/cannabidiol
Working on the endocannabinoid neurotransmitters
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Cannabinoidergic
Compounds that inhibit or block the activity of cannabinoid receptors
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Cannabinoid receptor antagonist
Cannabinoid_receptor_antagonist
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Yangonin
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
MDMB-BINACA
Synthetic cannabinoid
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
HU-210
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Epicatechin_gallate
Active metabolite of paracetamol
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
AM404
Synthetic cannabinoid
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
A-CHMINACA
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
ADB-5'Br-BUTINACA
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
2-Arachidonoylglycerol
Chemical compound
Anandamide Cannabidiol NADGly THC (dronabinol) O-1602 Antagonists PSB-CB5 O-1918 GPR55 Agonists 2-AGE (noladin ether) 2-ALPI Abnormal cannabidiol AM-251 CID1011163
Leelamine
GPR55
GPR55
GPR55
GPR55
Boy/Male
Indian, Punjabi, Sikh
Ocean of the Excellence
Male
English
English form of Greek Ioel (Hebrew Yowel), JOEL means "Jehovah is God" or "to whom Jehovah is God." In the bible, this is the name of many characters, including one of the minor prophets.Â
Boy/Male
Tamil
Great
Boy/Male
Tamil
Consciousness
Boy/Male
Tamil
Manjunatha | மாஂநà¯à®œà¯à®¨à®¾à®¤à®¾
Lord Shiva
Boy/Male
Indian, Sanskrit
Voice; Milk
Boy/Male
Bengali, Gujarati, Hindu, Indian, Jain, Kannada, Malayalam, Marathi, Sanskrit, Tamil, Telugu, Traditional
Great Among Kings; King; A Mighty King; Emperor; King of Kings
Girl/Female
Buddhist, Indian
Righteous Matter
Boy/Male
German
Strong Bear
Boy/Male
German
Resolute; Famous
GPR55
GPR55
GPR55
GPR55
GPR55